Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jan 23, 2013
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2013-01-22$2.82/sh+900$2,538→ 158,914 total - Purchase
Common Stock
2013-01-22$2.83/sh+315$891→ 159,229 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.